United States

People: Thomson Reuters Corp (TRI.N)

TRI.N on New York Stock Exchange

23 Aug 2019
Change (% chg)

$-1.61 (-2.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Peck, Kristin 

Ms. Kristin C. Peck is an Independent Director of the Company. Kristin Peck is Executive Vice President and Group President, U.S. Operations, Business Development and Strategy at Zoetis, a NYSE-listed global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines that was spun off by Pfizer in 2013. From October 2012 through April 2015, she served as Executive Vice President and Group President of Zoetis. Ms. Peck joined Pfizer in 2004 and held various positions, including Executive Vice President, Worldwide Business Development and Innovation; Senior Vice President, Worldwide Business Development, Strategy and Innovation; Vice President, Strategic Planning; Chief of Staff to the Vice Chairman; and Senior Director, Strategic Planning. She also served as a member of Pfizer’s Executive Leadership Team. Prior to joining Pfizer, Ms. Peck was a Principal at Boston Consulting Group. She holds a Bachelor’s degree from Georgetown University and a Master of Business Administration from Columbia Business School.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 200,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 200,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Thomson


James Smith


David Binet


Stephane Bello


Michael Friedenberg


Piotr Marczewski

As Of  30 Dec 2018